GMGrégoire Mercier

Grégoire Mercier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Grégoire Mercier has a total of 214 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative accuracy of a predictive algorithm versus cardiologist assessment for 90-day readmission in decompensated chronic heart failure

    by Grégoire Mercier, Clément Delmas, Fabien Huet, François Roubille

    Heart failure is a leading cause of hospital readmission globally. Few studies have compared the performance of artificial intelligence-based prediction mo


  • La comptabilité analytique hospitalière : entre efficience et légitimation

    by Grégoire Mercier

    Les récentes réformes inspirées de la nouvelle gestion publique font de la comptabilité analytique hospitalière une pièce maîtresse du financement et de la gouvernance des établissements de soins français. Les coûts unitaires par séjour alimentent en effet à la fois le processus d'élaboration des tarifs et les nouveaux instruments de gestion supposés améliorer l'efficience hospitalière. Ce travail confronte la comptabilité analytique en vigueur à une méthode basée sur les activités pour calculer les coûts unitaires d'un échantillon de 2130 interventions chirurgicales réalisées consécutivement au CHU de Montpellier en 2009. Il montre que les deux méthodes sont discordantes et que, en outre, la méthode actuelle reflète mal la complexité réelle de la prise en charge des patients au bloc opératoire. La théorie néoinstitutionnelle suggère que le développement de la comptabilité analytique hospitalière, structure organisationnelle formelle, est un processus isomorphique par lequel les établissements de santé internalisent le mythe rationalisé du calcul des coûts des séjours. Pour pouvoir répondre aux contraintes et à la complexité du réel, un certain degré de découplage entre cette comptabilité et l'activité réelle apparaît. La comptabilité analytique ne serait donc plus seulement un instrument au service de l'efficience des hôpitaux mais aussi un facteur de légitimation au sein d'un environnement fortement institutionnalisé. Dès lors se pose la question de la pertinence des tarifs et des outils de gestion alimentés par ces coûts unitaires au regard des objectifs poursuivis.

  • Open Access

    Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data

    by Junqing Xie, Kim López-Güell, Daniel Dedman, Talita Duarte-Salles, Raivo Kolde, Raúl López-Blasco, Álvaro Martínez, Gregoire Mercier, Alicia Abellan, Johnmary T. Arinze, et al.


  • Open Access

    Systematic screening for multimorbidities in patients with inflammatory rheumatic diseases enhanced preventive medication use and reduced hospitalisations: an exposed-non-exposed study

    by Claire Immediato Daien, Vera Georgescu, Guillaume Decarriere, Grégoire Mercier, Jacques Morel

    Rational Studies are needed to determine if multimorbidity screening and management reduce the rate of multimorbidity accumulation in patients with chronic inflammatory rheumatic diseases (IRD). Objectives This study evaluates the impact of systematic screening programme on patient care and hospitalisation rates. Methods Patients with IRD who participated in the screening programme (exposed patients) were identified within the French national health database and matched with controls. Two sets of analysis were performed: one with multivariate analysis and a second using a propensity score matching to ensure comparability between exposed patients and controls. The primary endpoint (PE) was a composite score assessing the dispensation of multimorbidity-preventing drugs, including vaccines, lipid-lowering agents, antiosteoporotic medications and antiplatelet drugs, during the year following the index date. Results The first analysis included 286 exposed patients and 858 controls, demonstrating a higher rate of meeting the PE in exposed patients (adjusted OR=1.6 (1.2–2.2), pConclusion Systematic multimorbidity screening in patients with IRD boosted preventive medication use and reduced hospital admissions, justifying time and resource allocation for screening.


  • Open Access

    PRADOC: A Multicenter Randomized Controlled Trial to Assess the Efficiency of PRADO‐IC, a Nationwide Pragmatic Transition Care Management Plan for Hospitalized Patients With Heart Failure in France

    by François Roubille, Jean‐Philippe Labarre, Frédéric Georger, Michel Galinier, Fanchon Herman, Philippe Berdague, Erika Nogue, Thibaut Petroni, Quentin Delbaere, Alexandre Malak, et al.

    Background: The PRADO‐IC (Programme de Retour à Domicile après une Insuffisance Cardiaque) is a transition care program designed to improve the coordination of care between hospital and home that was generalized in France in 2014. The PRADO‐IC consists of an administrative assistant who visits patients during hospitalization to schedule follow‐up visits. The aim of the present study was to evaluate the PRADO‐IC program based on the hypotheses provided by health authorities. Methods and Results: The PRADOC study is a multicenter, controlled, randomized, open‐label, mixed‐method trial of the transition program PRADO‐IC versus usual management in patients hospitalized with heart failure (standard of care group; NCT03396081). A total of 404 patients were recruited between April 2018 and May 2021. The mean patient age was 75 years (±12 years) in both groups. The 2 groups were well balanced regarding severity indices. At discharge, patients homogeneously received the recommended drugs. There was no difference between groups regarding hospitalizations for acute heart failure at 1 year, with 24.60% in the standard of care group and 25.40% in the PRADO‐IC group during the year following the index hospitalization (hazard ratio, 1.04 [95% CI, 0.69–1.56]; P =0.85) or cardiovascular mortality (hazard ratio, 0.67 [95% CI, 0.34–1.31]; P =0.24). Conclusions: The PRADO‐IC has not significantly improved clinical outcomes, though a trend toward reduced cardiovascular mortality is evident. These results will help in understanding how transitional care programs remain to be integrated in pathways of current patients, including telemonitoring, and to better tailor individualized approaches. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT03396081.


  • Open Access

    Predicting One-Year Mortality after Discharge Using Acute Heart Failure Score (AHFS)

    by Mariarosaria Magaldi, Erika Nogue, Nicolas Molinari, Nicola De Luca, Anne-Marie Dupuy, Florence Leclercq, Jean-Luc Pasquie, Camille Roubille, Grégoire Mercier, Jean-Paul Cristol, et al.

    Background: Acute heart failure (AHF) represents a leading cause of unscheduled hospital stays, frequent rehospitalisations, and mortality worldwide. The aim of our study was to develop a bedside prognostic tool, a multivariable predictive risk score, that is useful in daily practice, thus providing an early prognostic evaluation at admission and an accurate risk stratification after discharge in patients with AHF. Methods: This study is a subanalysis of the STADE HF study, which is a single-centre, prospective, randomised controlled trial enrolling 123 patients admitted to hospital for AHF. Here, 117 patients were included in the analysis, due to data exhaustivity. Regression analysis was performed to determine predictive variables for one-year mortality and/or rehospitalisation after discharge. Results: During the first year after discharge, 23 patients died. After modellisation, the variables considered to be of prognostic relevance in terms of mortality were (1) non-ischaemic aetiology of HF, (2) elevated creatinine levels at admission, (3) moderate/severe mitral regurgitation, and (4) prior HF hospitalisation. We designed a linear model based on these four independent predictive variables, and it showed a good ability to score and predict patient mortality with an AUC of 0.84 (95%CI: 0.76–0.92), thus denoting a high discriminative ability. A risk score equation was developed. During the first year after discharge, we observed as well that 41 patients died or were rehospitalised; hence, while searching for a model that could predict worsening health conditions (i.e., death and/or rehospitalisation), only two predictive variables were identified: non-ischaemic HF aetiology and previous HF hospitalisation (also included in the one-year mortality model). This second modellisation showed a more discrete discriminative ability with an AUC of 0.67 (95% C.I. 0.59–0.77). Conclusions: The proposed risk score and model, based on readily available predictive variables, are promising and useful tools to assess, respectively, the one-year mortality risk and the one-year mortality and/or rehospitalisations in patients hospitalised for AHF and to assist clinicians in the management of patients with HF aiming at improving their prognosis.


  • Open Access

    Weight Telemonitoring of Heart Failure Versus Standard of Care in a Real-World Setting: Results on Mortality and Hospitalizations in a 6-Month Nationwide Matched Cohort Study

    by François Roubille, Grégoire Mercier, Guila Lancman, Hélène Pasche, Sarah Alami, Cécile Delval, Antoine Bessou, Jade Vadel, Amayelle Rey, Stéphanie Duret, et al.

    Aims: Evaluating the benefit of telemonitoring in heart failure (HF) management in real-world settings is crucial for optimizing the healthcare pathway. The aim of this study was to assess the association between a 6-month application of the telemonitoring solution Chronic Care Connect™ (CCC) and mortality, HF hospitalizations, and associated costs compared with standard of care (SOC) in patients with a diagnosis of HF. Methods and results: From February 2018 to March 2020, a retrospective cohort study was conducted using the largest healthcare insurance system claims database in France (Système National des Données de Santé) linked to the CCC telemonitoring database of adult patients with an ICD-10-coded diagnosis of HF. Patients from the telemonitoring group were matched with up to two patients from the SOC group based on their high-dimensional propensity score, without replacement, using the nearest-neighbour method. A total of 1358 telemonitored patients were matched to 2456 SOC patients. The cohorts consisted of high-risk patients with median times from last HF hospitalization to index date of 17.0 (interquartile range: 7.0–66.0) days for the telemonitoring group and 27.0 (15.0–70.0) days for the SOC group. After 6 months, telemonitoring was associated with mortality risk reduction (hazard ratio [HR] 0.71, 95% confidence interval [CI] 0.56–0.89), a higher risk of first HF hospitalization (HR 1.81, 95% CI 1.55–2.13), and higher HF healthcare costs (relative cost 1.38, 95% CI 1.26–1.51). Compared with the SOC group, the telemonitoring group experienced a shorter average length of overnight HF hospitalization and fewer emergency visits preceding HF hospitalizations. Conclusion: The results of this nationwide cohort study highlight a valuable role for telemonitoring solutions such as CCC in the management of high-risk HF patients. However, for telemonitoring solutions based on weight and symptoms, consideration should be given to implement additional methods of assessment to recognize imminent worsening of HF, such as impedance changes, as a way to reduce mortality risk and the need for HF hospitalizations. Further studies are warranted to refine selection of patients who could benefit from a telemonitoring system and to confirm long-term benefits in high-risk and stable HF patients.


  • Open Access

    Impact of heatwaves, demographics, and environment on hospitalization rates in Paris

    by Rim Sabri, Manal Ahikki, Christophe Baehr, Michel Schneider, Grégoire Mercier

    Background: In the era of climate change, urban areas like Paris face heightened public health challenges, especially during heatwave occurrences. Although there is growing awareness, a research void exists regarding the intersectional effects of heatwaves, environmental variables, and demographic factors in dense urban locales such as Paris. Methods: Using a retrospective methodology, we collected comprehensive data from the National Health Data System and the Technical Agency for Information on Hospitalization. This encompassed 471,814 hospital stays from June to September, spanning from 2009 to 2019. Hospitalizations were systematically categorized into ten distinct clusters, each representing a specific set of medical conditions or reasons for hospitalization. These clusters include: (I) electrolyte disorders including dehydration and hyponatremia, (II) renal insufficiency, (III) urinary tract infections and lithiasis, (IV) septicemia, sepsis, and bacteremia, (V) heatstroke, (VI) neurocardiovascular diseases, (VII) chronic heart failure, (VIII) chronic respiratory diseases, (IX) diabetes mellitus, and (X) addictions and mental health issues. Each cluster is defined based on specific criteria, including diagnostic codes and clinical characteristics, allowing for a more precise analysis of hospitalization trends in relation to environmental factors such as heatwaves. Days identified as heatwaves were determined using a percentile-based approach. The study examined the correlations between hospitalization rates and various determinants using mixed-effects log-linear regression models. Results: Our study utilized a comprehensive dataset covering 2,184,193 residents across 20 districts in Paris. The data reflected a range of differences in demographics, building characteristics, and reasons for hospitalization. Notably, the age group over 75 was identified as a significant factor influencing hospitalization rates. This was further analyzed in conjunction with environmental metrics, including peak temperatures and the FDEP15 index. Conclusions: The intricate web of demographics, environmental stimuli, and heatwave events profoundly shapes public health trajectories in Paris. As the climate crisis deepens, there’s an urgent call for customized healthcare interventions, especially targeting the vulnerable elderly demographic.


  • Open Access

    Relationships between the COVID-19 lockdown, socioeconomic factors and acute coronary syndrome hospitalisations in France

    by Rodney Plat, Maria Vasile, François Roubille, Grégoire Mercier

    Introduction: Worldwide, the COVID-19 pandemic has been associated with an overall drop in acute coronary syndrome (ACS) hospitalizations. Additionally, there is a well-known association between ACS and socioeconomic status. This study aims to assess the COVID-19 effect on ACS admissions in France during the first national lockdown and investigate the factors associated with its spatial heterogeneity. Materials and methods: In this retrospective study, we used the French hospital discharge database (PMSI) to estimate ACS admission rates in all public and private hospitals in 2019 and 2020. A negative binomial regression explored the nationwide change in ACS admissions during lockdown compared with 2019. A multivariate analysis explored the factors associated with the ACS admission incidence rate ratio (IRR, 2020 incidence rate/2019 incidence rate) variation at the county level. Results: We found a significant but geographically heterogeneous nationwide reduction in ACS admissions during lockdown (IRR 0·70 [0·64–0·76]). After adjustment for cumulative COVID-19 admissions and the ageing index, a higher share of people on short-term working arrangements during lockdown at the county level was associated with a lower IRR, while a higher share of individuals with a high school degree and a higher density of acute care beds were associated with a higher ratio. Conclusions: During the first national lockdown, there was an overall decrease in ACS admissions. Local provision of inpatient care and socioeconomic determinants linked to occupation were independently associated with the variation in hospitalizations.

  • Open Access

    Organisational Impact of a Remote Patient Monitoring System for Heart Failure Management: The Experience of 29 Cardiology Departments in France

    by Sarah Alami, Laurène Courouve, Guila Lancman, Pierrette Gomis, Gisele Al-Hamoud, Corinne Laurelli, Hélène Pasche, Gilles Chatellier, Grégoire Mercier, François Roubille, et al.

    Remote patient monitoring (RPM) for the management of patients with chronic heart failure (CHF) has been widely studied from clinical and health-economic points of view. In contrast, data on the organisational impact of this type of RPM are scarce. The objective of the present study of cardiology departments (CDs) in France was to describe the organisational impact of the Chronic Care ConnectTM (CCCTM) RPM system for CHF. An organisational impact map for health technology assessment was used to identify and define the criteria evaluated in the present survey, including the care process, equipment, infrastructure, training, skill transfers, and the stakeholders’ abilities to implement the care process. In April 2021, an online questionnaire was sent to 31 French CDs that were using CCCTM for CHF management: 29 (94%) completed the questionnaire. The survey results showed that CDs progressively modified their organisational structures upon or shortly after the implementation of the RPM device. Twenty-four departments (83%) had created a dedicated team, sixteen (55%) had provided dedicated outpatient consultations for patients with an emergency alert, and twenty-five (86%) admitted patients directly (i.e., avoiding the need to attend the emergency department). The present survey is the first to have assessed the organisational impact of the implementation of the CCCTM RPM device for CHF management. The results highlighted the variety of organisational structures, which tended to structure with the use of the device.